Sponsored by Ultragenyx Pharmaceutical Inc.
Variant ID | 140 |
---|---|
Genomic Coordinate (GRCh38) | g.22076459T>C |
Variant | c.421T>C |
Variant Start Position | 421 |
Location | Exon 4 |
Amino Acid Change | p.Ser141Pro |
ACMG Call | - |
ACMG Call Last Revised Date | 4/28/2021 |
Predicted ACMG Call | Likely Pathogenic | Effect Type | Missense |
Variant Type | SNV |
PMID | 16636593, 26894575, 34806794 |
Article Count | 3 |
Times Observed | < 3 |
Clinical Phenotype | - |
ACMG Categories | pm2, pp3 |
ACMG Explanations | pm2: chrX:22094577 ref:T alt:C was not found in gnomAD exomes or genomes. pp3: The SIFT, MutationTaster, and PolyPhen predictions agree that this variant is possibly or probably damaging. |
Variant in Clinvar | No |
ClinVar Classification | - |
Categories In Literature | - |
No Contrary Evidence Found | Yes |
ExAC Allele Frequency | - |
Thousand Genomes Allel Frequency | - |
Ontology Relations | - |
hg19 Mapping Failed | No |
Literature Alleles | X-22094577-T-C |
GnomAD Alleles | - |
DBNSFP Alleles | X-22094577-T-C |
Other Alleles | X-22094577-TCC-CCT X-22094577-TCC-CCA X-22094577-TCC-CCG |
Note | nan |
Warnings | - |